ANDREW DOUTHITT: Open Payments
NPI 1801381256 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 76 payments from 18 companies in 2025. Trend: 2023 $852 · 2024 $1,063 · 2025 $1,509
Food & beverage: $1,433Education: $76
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $275 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $264 |
| Calliditas Therapeutics US Inc. | 8 | $179 |
| Abbott Laboratories | 1 | $123 |
| Novo Nordisk Inc | 5 | $120 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Travere Therapeutics, Inc. | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Ardelyx, Inc. | 3 | $59 |
| Vantive US Healthcare LLC | 1 | $48 |
Products named: Kerendia, KRYSTEXXA, TARPEYO, CARDIOMEMS, Ozempic, JARDIANCE, JYNARQUE, TAVNEOS.
Industry payments across OK — which companies pay providers there.
